Homozygous deletion of Smad4 is found in about 30% of pancreatic cancer patients, inactivation of Smad4 in 20% of patients, and allelic loss of its chromosome is found in 90% [42]. Here, SMAD4 is linked to familial pancreatic carcinoma.